Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

Health insurance companies, including CVS Caremark, are altering coverage for GLP-1 weight loss medications like Zepbound, ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

Weight-loss supplements recommended by influencers on social mead are generally ineffective for weight loss, but do have some benefits.

Retirees looking for dividend growth stocks at a reasonable price have ample reasons to look outside of America, especially ...

For more health information, please see recent studies about Vitamin D that may reduce dangerous complications in diabetes ...

Gov. Maura Healey signed the new fiscal year's $61 billion operating plan on Friday, marking the earliest the state has ...

GLP-1 weight loss patches are everywhere but do they actually work as these trendy patches promise Ozempic-like results ...

MariTide, a new drug from Amgen, helped some people with obesity lose up to 20% of their body weight. In a phase 2 trial, a new GLP-1 drug helped people lose up to 20% of their body weight over a year ...

Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...